SouthState’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152 Sell
11
-59
-84% -$804 ﹤0.01% 1358
2026
Q2
$949 Buy
70
+19
+37% +$227 ﹤0.01% 1119
2026
Q1
$306 Sell
51
-160
-76% -$1.2K ﹤0.01% 1232
2025
Q4
$1.51K Sell
211
-15
-7% -$119 ﹤0.01% 1043
2025
Q3
$2.41K Sell
226
-3,688
-94% -$36.2K ﹤0.01% 903
2025
Q2
$37.9K Buy
3,914
+3,714
+1,857% +$38.3K ﹤0.01% 544
2025
Q1
$2.98K Buy
200
+195
+3,900% +$3K ﹤0.01% 1093
2024
Q4
$75 Hold
5
– – ﹤0.01% 667
2024
Q3
$96 Hold
5
– – ﹤0.01% 603
2024
Q2
$104 Sell
5
-47
-90% -$934 ﹤0.01% 631
2024
Q1
$978 Hold
52
– – ﹤0.01% 647
2023
Q4
$750 Sell
52
-150
-74% -$2.04K ﹤0.01% 578
2023
Q3
$3.51K Hold
202
– – ﹤0.01% 543
2023
Q2
$4.2K Sell
202
-15
-7% -$326 ﹤0.01% 518
2023
Q1
$5.1K Hold
217
– – ﹤0.01% 566
2022
Q4
$6.06K Sell
217
-355
-62% -$9.08K ﹤0.01% 605
2022
Q3
$13K Sell
572
-774
-58% -$23.4K ﹤0.01% 508
2022
Q2
$45K Buy
1,346
+455
+51% +$15.9K ﹤0.01% 413
2022
Q1
$31K Buy
891
+411
+86% +$14.1K ﹤0.01% 489
2021
Q4
$14K Buy
480
+9
+2% +$293 ﹤0.01% 528
2021
Q3
$15K Sell
471
-2,063
-81% -$66K ﹤0.01% 457
2021
Q2
$77K Buy
+2,534
New +$83.4K 0.01% 276

Other funds holding OGN

SouthState's OGN Position: Q3 2026 in Review

SouthState reduced its Organon & Co (OGN) stake by 84% in Q3 2026, selling an estimated $804 and leaving 11 shares worth $152. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

SouthState first reported a position in OGN in Q2 2021 and has held it in 22 quarters since. The position peaked at $77K in Q2 2021. 507 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • SouthState held 11 shares of Organon & Co worth $152 as of Q3 2026.
  • SouthState sold 59 Organon & Co shares in Q3 2026, an estimated $804.
  • Organon & Co made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1358 holding.
  • SouthState first reported a position in Organon & Co in Q2 2021 and has held it in 22 quarters since.
  • SouthState's Organon & Co position peaked at $77K in Q2 2021.
  • 507 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.